Abstract:E3 ubiquitin ligases are part of various families of proteins and include hundreds of members, which play key roles in all aspects of cell biology. They generally regulate the half-life of other proteins but can also modulate their cellular localization and functions. The MARCH family of ubiquitin ligases is composed of 11 members and two closely related proteins, MARCH1 and MARCH8, share similar targets, while being active in different cell types. Although they appear to target principally immune cell components, such as MHC class II molecules and the co-stimulatory molecule CD86, the repertory of their targets remains to be fully documented. Here, to further define the MARCH1’s interactome, we adapted a proximity-dependent biotin identification (BioID)-based screening approach in live HEK293 cells. We transfected a fusion protein consisting of mouse MARCH1 linked to YFP at its N-terminus and to the biotin ligase of at its C-terminus. Upon transient overexpression of this construct in the presence of exogenous biotin, we could recover biotinylated proteins that are presumably found within 10nm of MARCH1. To help in the identification of down-regulated specific targets, we compared MARCH1’s interactome with the one obtained using a ubiquitination-deficient MARCH1 mutant (MARCH1W104A). CD98 and CD71, two previously described targets of MARCH1, were identified in this screen. Of 16 other biotinylated proteins identified by semi-quantitative mass spectrometry, 10 were tested directly by flow cytometry to monitor their expression in the presence or absence of transfected MARCH1. The protein levels of five of these endogenous targets, CD29, CD112, NKCC1, CD147 and SNAT2, confirmed their negative regulation by MARCH1 in this system. SNAT2 was particularly sensitive to the presence of MARCH1 and was found to be ubiquitinated on Western blots following immunoprecipitation. Thus, BioID2 is an effective mean of characterizing the interactome of MARCH1 and the identification of SNAT2 suggests a role of this ubiquitin ligase in cellular metabolism.

Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86

MARCH9‐mediated Ubiquitination Regulates MHC I Export from the TGN

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation

MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα

MARCH3 Attenuates IL-1β-triggered Inflammation by Mediating K48-linked Polyubiquitination and Degradation of IL-1RI.

UBE2G1 governs the destruction of cereblon neomorphic substrates.

MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex

The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation

The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation

The E3 Ubiquitin Ligase Mule Acts Through the ATM–p53 Axis to Maintain B Lymphocyte Homeostasis

The Membrane-Associated E3 Ubiquitin Ligase MARCH3 Downregulates the IL-6 Receptor and Suppresses Colitis-Associated Carcinogenesis

Molecular characteristics and immune function of ubiquitin C-terminal hydrolase-L3 in <i>Macrobrachium nipponense</i>

Multiple ubiquitin ligases protect human genome integrity by targeting cancer-associated APOBEC3 deaminases for degradation

A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins—UBL3

Deubiquitinase USP3 in Macrophages Impaires the Inflammatory Responses in the Colitis Model

A PROXIMITY LIGATION SCREEN IDENTIFIES SNAT2 AS A NOVEL TARGET OF THE MARCH1 E3 UBIQUITIN LIGASE

Role of UCHL3 in Health and Disease

MARCH8 Mediates K27-Linked Polyubiquitination of IL-7 Receptor α to Negatively Regulate IL-7-Triggered T Cell Homeostasis

Ubc13 Promotes K63-Linked Polyubiquitination of NLRP3 to Activate Inflammasome.